Accueil | Epicentre
Latest news
News
Waiting Is Not an Option: MSF calls for broader access to ERVEBO® vaccine during Bundibugyo Ebola outbreak
Published on 09.11.2026
Lire l'actualité :
Waiting Is Not an Option: MSF calls for broader access to ERVEBO® vaccine during Bundibugyo Ebola outbreak
News
First participant vaccinated in pivotal Phase 2/3 Bundibugyo vaccine trial in DRC
Published on 23.10.2026
Lire l'actualité :
First participant vaccinated in pivotal Phase 2/3 Bundibugyo vaccine trial in DRC
News
Over a decade of seasonal malaria chemoprevention in Békourou in Chad: How effective is it today?
Published on 07.10.2026
Lire l'actualité :
Over a decade of seasonal malaria chemoprevention in Békourou in Chad: How effective is it today?
Latest publications
Extended genotyping of human papillomavirus and AI-assisted cervical visual evaluation for prediction of cervical precancer in nine resource-limited settings (PAVE): a cross-sectional study.
The Lancet Obstetrics, Gynaecology, & Women’s Health 2026, 2 (11). doi: 10.1016/S3050-5038(26)00231-1 Epub 2026 11 03
Published on
Multi-omics, multi-tissue analysis reveal role of extracellular matrix remodeling and sphingolipid homeostasis in edematous malnutrition (kwashiorkor).
Biomarker research 2026 Oct 28; 14(1); . doi: 10.1186/s40364-026-01016-9. Epub 2026 10 28
Published on
Outcomes of home-based versus facility-based care for mild diphtheria during a large epidemic in Kano State, Nigeria: A retrospective matched cohort study.
PLoS medicine 2026 Oct 26; 23(10); . doi: 10.1371/journal.pmed.1005097. Epub 2026 10 26
Published on
Discover our training courses
Transmitting and transferring epidemiological knowledge is an integral part of Epicentre's mission. Training courses are provided throughout the year to MSF staff and beyond.